“Stem-cell-derived” skin care
This article was originally published in The Rose Sheet
Executive Summary
Proteonomix's line of "stem-cell-derived" anti-aging cosmetics will debut in first quarter of 2009, biotech firm announces Oct. 8. The serum, day cream, night cream, cleanser and exfoliator rely on a proprietary matrix of proteins called Matrix NC-138 - derived from culture medium of non-embryonic, human stem cell derivatives - to stimulate collagen production, which leads to a reduction of wrinkles, company says. Subsidiary Proteoderm's anti-aging solutions "can bring patients higher satisfaction and results, working to revitalize and rejuvenate cells to help drastically reverse the effects of aging," according to the release. Line will be distributed through physicians' offices. Firm changed its name from National Stem Cell Holdings to Proteonomix in September (1"The Rose Sheet" Sept. 1, 2008, In Brief)